Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$0.01 - $0.61 $100 - $6,100
-10,000 Reduced 4.44%
215,000 $2,000
Q4 2023

Feb 08, 2024

SELL
$0.42 - $0.72 $231,420 - $396,720
-551,000 Reduced 71.01%
225,000 $141,000
Q3 2023

Nov 08, 2023

BUY
$0.6 - $1.53 $105,600 - $269,280
176,000 Added 29.33%
776,000 $465,000
Q2 2023

Aug 09, 2023

BUY
$1.05 - $1.63 $94,500 - $146,700
90,000 Added 17.65%
600,000 $677,000
Q1 2023

May 11, 2023

BUY
$1.2 - $2.73 $114,000 - $259,350
95,000 Added 22.89%
510,000 $688,000
Q4 2022

Feb 06, 2023

BUY
$1.71 - $3.61 $59,850 - $126,350
35,000 Added 9.21%
415,000 $771,000
Q3 2022

Nov 08, 2022

BUY
$1.9 - $8.63 $266,000 - $1.21 Million
140,000 Added 58.33%
380,000 $935,000
Q2 2022

Aug 12, 2022

BUY
$2.13 - $9.01 $477,120 - $2.02 Million
224,000 Added 1400.0%
240,000 $586,000
Q1 2022

May 12, 2022

BUY
$6.28 - $15.59 $100,480 - $249,440
16,000 New
16,000 $128,000
Q4 2021

Feb 03, 2022

SELL
$14.7 - $28.67 $2.23 Million - $4.36 Million
-152,000 Closed
0 $0
Q3 2021

Nov 08, 2021

BUY
$24.31 - $33.6 $291,720 - $403,200
12,000 Added 8.57%
152,000 $4.32 Million
Q2 2021

Aug 10, 2021

BUY
$26.09 - $40.4 $260,900 - $404,000
10,000 Added 7.69%
140,000 $4.72 Million
Q1 2021

May 11, 2021

BUY
$33.06 - $56.93 $330,600 - $569,300
10,000 Added 8.33%
130,000 $4.97 Million
Q4 2020

Feb 11, 2021

BUY
$39.09 - $57.4 $4.69 Million - $6.89 Million
120,000 New
120,000 $5.02 Million

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Longitude (Cayman) Ltd. Portfolio

Follow Longitude (Cayman) Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Longitude (Cayman) Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Longitude (Cayman) Ltd. with notifications on news.